Fu Zhao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Fu Zhao has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
Zhikai Xiahou
China Institute of Sport and Health Science, Beijing Sport University, Beijing 100084, China
2 shared publicationsGaofeng Ni
Department of Breast Surgery, Yantaishan Hospital Affiliated to Binzhou Medical University, Yantai 264003, China
1 shared publicationHaiyu Li
Department of Clinical Laboratory, Songjiang Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
1 shared publicationHongling Jia
The First Clinical Medical College of Shandong University of Traditional Chinese Medicine, Jinan 250014, China
1 shared publication- Hongyan Zang
Department of Breast Surgery, Yantaishan Hospital Affiliated to Binzhou Medical University, Yantai, China
1 shared publication Qinghan Zhang
Department of Otolaryngology, Songjiang Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
1 shared publication
Latest Publications
- Open Access
- 13 January 2025
- Published by Elsevier in Translational Oncology
- Vol. 52, 102280
MAZ-mediated tumor progression and immune evasion in hormone receptor-positive breast cancer: Targeting tumor microenvironment and PCLAF+ subtype-specific therapy
- 13 January 2025
- Published by Elsevier in Translational Oncology
- Vol. 52, 102280
Open AccessMAZ-mediated tumor progression and immune evasion in hormone receptor-positive breast cancer: Targeting tumor microenvironment and PCLAF+ subtype-specific therapy
- Open Access
- 1 January 2025
- Published by Ivyspring International Publisher in Journal of Cancer
- Vol. 16 (1) , 288-314
The cellular signaling crosstalk between memory B cells and tumor cells in nasopharyngeal carcinoma cannot be overlooked: Their involvement in tumor progression and treatment strategy is significant
Background: Nasopharyngeal carcinoma (NPC) refers to a cancerous tumor that develops in the upper and side walls of the nasopharyngeal cavity. Typically, individuals are often diagnosed with the disease when it has already progressed significantly, and those with advanced NPC tend to have an unfavorable outlook in terms of response rate to targeted treatments and overall clinical survival. Various molecular mechanisms, including Myeloid-derived suppressor cells and factors like PD-L1, have been explored to enhance the outcome of NPC. However, there are still challenges to be addressed in terms of identifying symptoms at an early stage, making precise predictions about the chances of cancer returning and spreading, and devising successful approaches for treatment. The activation of B cells and their corresponding pathways holds potential for developing enhanced immune therapeutic strategies. Nevertheless, the comprehensive understanding of the intricate association between B cells and NPC tumor cells remains incomplete. Hence, this study employed single-cell multi-omics analysis to investigate the molecular biomarkers and prognostic factors linked to B cell subpopulations in human NPC while examining the underlying mechanisms.
- 1 January 2025
- Published by Ivyspring International Publisher in Journal of Cancer
- Vol. 16 (1) , 288-314
Open AccessThe cellular signaling crosstalk between memory B cells and tumor cells in nasopharyngeal carcinoma cannot be overlooked: Their involvement in tumor progression and treatment strategy is significant
Background: Nasopharyngeal carcinoma (NPC) refers to a cancerous tumor that develops in the upper and side walls of the nasopharyngeal cavity. Typically, individuals are often diagnosed with the disease when it has already progressed significantly, and those with advanced NPC tend to have an unfavorable outlook in terms of response rate to targeted treatments and overall clinical survival. Various molecular mechanisms, including Myeloid-derived suppressor cells and factors like PD-L1, have been explored to enhance the outcome of NPC. However, there are still challenges to be addressed in terms of identifying symptoms at an early stage, making precise predictions about the chances of cancer returning and spreading, and devising successful approaches for treatment. The activation of B cells and their corresponding pathways holds potential for developing enhanced immune therapeutic strategies. Nevertheless, the comprehensive understanding of the intricate association between B cells and NPC tumor cells remains incomplete. Hence, this study employed single-cell multi-omics analysis to investigate the molecular biomarkers and prognostic factors linked to B cell subpopulations in human NPC while examining the underlying mechanisms.